Synergetic regulation of most cancers cells and exhausted T cells to battle chilly tumors with a fluorinated EGCG-based nanocomplex | Journal of Nanobiotechnology


  • Morris EC, Neelapu SS, Giavridis T, Sadelain M. Cytokine launch syndrome and related neurotoxicity in most cancers immunotherapy. Nat Rev Immunol. 2022;22(2):85–96.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chowell D, Yoo SK, Valero C, Pastore A, Krishna C, Lee M, Hoen D, Shi H, Kelly DW, Patel N, Makarov V, Ma X, Vuong L, Sabio EY, Weiss Okay, Kuo F, Lenz TL, Samstein RM, Riaz N, Adusumilli PS, Balachandran VP, Plitas G, Ari Hakimi A, Abdel-Wahab O, Shoushtari AN, Postow MA, Motzer RJ, Ladanyi M, Zehir A, Berger MF, Gonen M, Morris LGT, Weinhold N, Chan T. A., Improved prediction of immune checkpoint blockade efficacy throughout a number of most cancers sorts. Nat Biotechnol. 2022;40(4):499–506.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kubli SP, Berger T, Araujo DV, Siu LL, Mak TW. Past immune checkpoint blockade: rising immunological methods. Nat Rev Drug Discov. 2021;20(12):899–919.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ribas A, Wolchok JD. Most cancers immunotherapy utilizing checkpoint blockade. Science. 2018;359(6382):1350–5.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Han HS, Jeong S, Kim H, Kim HD, Kim AR, Kwon M, Park SH, Woo CG, Kim HK, Lee KH, Search engine optimisation SP, Kang HW, Kim WT, Kim WJ, Yun SJ, Shin EC. TOX-expressing terminally exhausted tumor-infiltrating CD8(+) T cells are reinvigorated by co-blockade of PD-1 and TIGIT in Bladder most cancers. Most cancers Lett. 2021;499:137–47.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T cell exhaustion throughout power viral An infection and Most cancers. Annu Rev Immunol. 2019;37:457–95.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Arcia-Anaya D, Elliott T. STAT5A antagonizes TOX in CD8(+) T cell exhaustion. Nat Rev Immunol. 2023;23(2):73.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chen C, Ni X, Jia S, Liang Y, Wu X, Kong D, Ding D. Massively evoking immunogenic cell demise by targeted mitochondrial oxidative stress utilizing an AIE Luminogen with a twisted molecular construction. Adv Mater 2019, 31 (52), e1904914.

  • Finlay D, Cantrell DA. Metabolism, migration and reminiscence in cytotoxic T cells. Nat Rev Immunol. 2011;11(2):109–17.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen SW, Zhu SQ, Pei X, Qiu BQ, Xiong D, Lengthy X, Lin Okay, Lu F, Xu JJ, Wu YB. Most cancers cell-derived exosomal circUSP7 induces CD8(+) T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC. Mol Most cancers. 2021;20(1):144.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kroy DC, Ciuffreda D, Cooperrider JH, Tomlinson M, Hauck GD, Aneja J, Berger C, Wolski D, Carrington M, Wherry EJ, Chung RT, Tanabe KK, Elias N, Freeman GJ, de Kruyff RH, Misdraji J, Kim AY, Lauer GM. Liver setting and HCV replication have an effect on human T-cell phenotype and expression of inhibitory receptors. Gastroenterology. 2014;146(2):550–61.

    Article 
    PubMed 

    Google Scholar
     

  • Wu Y, Ju Q, Jia Okay, Yu J, Shi H, Wu H, Jiang M. Correlation between intercourse and efficacy of immune checkpoint inhibitors (PD-1 and CTLA-4 inhibitors). Int J Most cancers. 2018;143(1):45–51.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Alfei F, Kanev Okay, Hofmann M, Wu M, Ghoneim HE, Roelli P, Utzschneider DT, von Hoesslin M, Cullen JG, Fan Y, Eisenberg V, Wohlleber D, Steiger Okay, Merkler D, Delorenzi M, Knolle PA, Cohen CJ, Thimme R, Youngblood B, Zehn D. TOX reinforces the phenotype and longevity of exhausted T cells in power viral An infection. Nature. 2019;571(7764):265–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sekine T, Perez-Potti A, Nguyen S, Gorin JB, Wu VH, Gostick E, Llewellyn-Lacey S, Hammer Q, Falck-Jones S, Vangeti S, Yu M, Smed-Sorensen A, Gaballa A, Uhlin M, Sandberg JK, Brander C, Nowak P, Goepfert PA, Worth DA, Betts MR, Buggert M. TOX is expressed by exhausted and polyfunctional human effector reminiscence CD8(+) T cells. Sci Immunol. 2020;5:49.

    Article 

    Google Scholar
     

  • Wu P, Zhang H, Solar M, Mao S, He Q, Shi Y, Deng Y, Dong Z, Xu Q, Zhao C, Zhang W, Solar B. Manipulating offense and Protection Signaling to Struggle Chilly tumors with Provider-Free Nanoassembly of Fluorinated Prodrug and siRNA. Adv Mater. 2022;34(38):2203019.

    Article 
    CAS 

    Google Scholar
     

  • Abdel-Hakeem MS, Manne S, Beltra JC, Stelekati E, Chen Z, Nzingha Okay, Ali MA, Johnson JL, Giles JR, Mathew D, Greenplate AR, Vahedi G, Wherry EJ. Epigenetic scarring of exhausted T cells hinders reminiscence differentiation upon eliminating power antigenic stimulation. Nat Immunol. 2021;22(8):1008–19.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang W, Saeed M, Zhou Y, Yang L, Wang D, Yu H. Non-viral gene supply for most cancers immunotherapy. J Gene Med 2019, 21 (7), e3092.

  • Huang X, Wu G, Liu C, Hua X, Tang Z, Xiao Y, Chen W, Zhou J, Kong N, Huang P, Shi J, Tao W. Intercalation-driven formation of siRNA nanogels for Most cancers Remedy. Nano Lett. 2021;21(22):9706–14.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wu P, Yin S, Liu T, Ding D, Wang Okay. Constructing-block crosslinking micelles for enhancing mobile transfection of biocompatible polycations. Sci China Mater 2020.

  • Li Z, Wang Y, Shen Y, Qian C, Oupicky D, Solar M. Concentrating on pulmonary Tumor microenvironment with CXCR4-inhibiting nanocomplex to reinforce anti-PD-L1 immunotherapy. Sci Adv. 2020;6(20):eaaz9240.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shen W, Wang Q, Shen Y, Gao X, Li L, Yan Y, Wang H, Cheng Y. Inexperienced Tea Catechin dramatically promotes RNAi mediated by low-molecular-weight polymers. ACS Cent Sci. 2018;4(10):1326–33.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wu P, Zhang H, Yin Y, Solar M, Mao S, Chen H, Deng Y, Chen S, Li S, Solar B. Engineered EGCG-Containing Biomimetic nanoassemblies as efficient supply platform for enhanced Most cancers Remedy. Adv Sci. 2022;9(15):2105894.

    Article 
    CAS 

    Google Scholar
     

  • Rawangkan A, Wongsirisin P, Namiki Okay, Iida Okay, Kobayashi Y, Shimizu Y, Fujiki H, Suganuma M. Inexperienced Tea Catechin is another Immune checkpoint inhibitor that inhibits PD-L1 expression and lung Tumor development. Molecules. 2018;23(8):2071.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gao Z, Jia S, Ou H, Hong Y, Shan Okay, Kong X, Wang Z, Feng G, Ding D. An Activatable Close to-Infrared Afterglow Theranostic Prodrug with Self-sustainable magnification impact of immunogenic cell demise. Angew Chem Int Ed Engl 2022, 61 (40), e202209793.

  • Li J, Gao H, Liu R, Chen C, Zeng S, Liu Q, Ding D. Endoplasmic reticulum focused AIE bioprobe as a extremely environment friendly inducer of immunogenic cell demise. Sci China Chem. 2020;63(10):1428–34.

    Article 
    CAS 

    Google Scholar
     

  • Wu P, Luo X, Wu H, Zhang Q, Dai Y, Solar M. Environment friendly and focused chemo-gene supply with self-assembled fluoro-nanoparticles for liver fibrosis remedy and recurrence. Biomaterials. 2020;261:120311.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xiao YP, Zhang J, Liu YH, Huang Z, Wang B, Zhang YM, Yu XQ. Cross-linked polymers with fluorinated bridges for environment friendly gene supply. J Mater Chem B. 2017;5(43):8542–53.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yang P, Peng Y, Feng Y, Xu Z, Feng P, Cao J, Chen Y, Chen X, Cao X, Yang Y, Jie J. Immune Cell-Derived Extracellular vesicles – New Methods in Most cancers Immunotherapy. Entrance Immunol. 2021;12:771551.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lv J, Cheng Y. Fluoropolymers in biomedical functions: state-of-the-art and future views. Chem Soc Rev. 2021;50(9):5435–67.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang M, Liu H, Li L, Cheng Y. A fluorinated dendrimer achieves glorious gene transfection efficacy at extraordinarily low nitrogen to phosphorus ratios. Nat Commun. 2014;5:3053.

    Article 
    PubMed 

    Google Scholar
     

  • Xu J, Lv J, Zhuang Q, Yang Z, Cao Z, Xu L, Pei P, Wang C, Wu H, Dong Z, Chao Y, Wang C, Yang Okay, Peng R, Cheng Y, Liu Z. A basic technique in the direction of customized nanovaccines primarily based on fluoropolymers for post-surgical most cancers immunotherapy. Nat Nanotechnol. 2020;15(12):1043–52.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ren F, Li Z, Li Okay, Zheng X, Shi J, Zhang C, Guo H, Tong B, Xi L, Cai Z, Dong Y. Donor technique for selling nonradiative decay to realize an environment friendly photothermal remedy for treating most cancers. Sci China Chem. 2021;64(9):1530–9.

    Article 
    CAS 

    Google Scholar
     

  • Shao H, Cheng S, Yao M, Ji X, Zhong H, Wang D, Fan X, Li Q, Zhou J, Zhang Y, Peng F. A pH-response chemotherapy synergistic photothermal remedy for Tumor suppression and bone regeneration by mussel-inspired mg implant. Regen Biomater. 2021;8(6):rbab053.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, Sato E, Fukuoka S, Tada Y, Tanaka A, Morikawa H, Kawazoe A, Kinoshita T, Shitara Okay, Sakaguchi S, Nishikawa H. PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of most cancers. Proc Natl Acad Sci U S A. 2019;116(20):9999–10008.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yu X, Chen L, Liu J, Dai B, Xu G, Shen G, Luo Q, Zhang Z. Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver Metastasis. Nat Commun 2019, 10 (1).

  • Yu J, Inexperienced MD, Li S, Solar Y, Journey SN, Choi JE, Rizvi SM, Qin A, Waninger JJ, Lang X, Chopra Z, El Naqa I, Zhou J, Bian Y, Jiang L, Tezel A, Skvarce J, Achar RK, Sitto M, Rosen BS, Su F, Narayanan SP, Cao X, Wei S, Szeliga W, Vatan L, Mayo C, Morgan MA, Schonewolf CA, Cuneo Okay, Kryczek I, Ma VT, Lao CD, Lawrence TS, Ramnath N, Wen F, Chinnaiyan AM, Cieslik M, Alva A, Zou W. Liver Metastasis restrains immunotherapy efficacy through macrophage-mediated T cell elimination. Nat Med. 2021;27(1):152–64.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Music J, Jia X, Ariga Okay. Strategies with Nanoarchitectonics for Small molecules and nanostructures to control dwelling cells. Small Strategies. 2020;4(10):2000500.

    Article 
    CAS 

    Google Scholar
     

  • Li Q, Liu J, Fan H, Shi L, Deng Y, Zhao L, Xiang M, Xu Y, Jiang X, Wang G, Wang L, Wang Z. IDO-inhibitor potentiated immunogenic chemotherapy abolishes major Tumor development and eradicates metastatic lesions by concentrating on distinct compartments inside Tumor microenvironment. Biomaterials. 2021;269:120388.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ni X, Zhang X, Duan X, Zheng HL, Xue XS, Ding D. Close to-Infrared Afterglow luminescent aggregation-Induced Emission dots with Ultrahigh Tumor-to-liver Sign ratio for promoted image-guided Most cancers Surgical procedure. Nano Lett. 2019;19(1):318–30.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhao Z, Chen C, Wu W, Wang F, Du L, Zhang X, Xiong Y, He X, Cai Y, Kwok RTK, Lam JWY, Gao X, Solar P, Phillips DL, Ding D, Tang BZ. Extremely environment friendly photothermal nanoagent achieved by harvesting power through excited-state intramolecular movement inside nanoparticles. Nat Commun. 2019;10(1):768.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wu Q, Wang Q, Tang X, Xu R, Zhang L, Chen X, Xue Q, Wang Z, Shi R, Wang F, Ju F, Zhang B, Zhou YL. Correlation between sufferers’ age and most cancers immunotherapy efficacy. Oncoimmunology 2019, 8 (4), e1568810.

  • Related Articles

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Articles